TEMPEST THERAPEUTICS INC (TPST) Stock Income Statement
NASDAQ:TPST - Nasdaq - US87978U2078 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | N/A | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 42.03M | 29.16M | 34.64M | 26.99M | 35.97M | |||
| Research and Development | 28.48M | 17.50M | 22.53M | 17.17M | 20.37M | |||
| Selling, General, and Administrative Expenses | 13.55M | 11.66M | 12.11M | 9.82M | 15.60M | |||
| Operating Income | -42.03M | -29.16M | -34.64M | -26.99M | -35.97M | |||
| Interest Income/Expense | 183.00K | -334.00K | -1.62M | -1.28M | 160.00K | |||
| Other Income/Expense | N/A | N/A | 550.00K | -30.00K | -590.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -41.84M | -29.49M | -35.71M | -28.30M | -36.41M | |||
| Income Tax | 0.00 | 0.00 | 0.00 | N/A | N/A | |||
| Net Income | -41.84M | -29.49M | -35.71M | -28.30M | -36.41M | |||
| EBITDA | -41.64M | -28.78M | -34.00M | -26.62M | -35.82M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -19.50 | -24.87 | -3.09 | -7.47 | -28.89 | |||
| Non GAAP EPS | -10.14 | -1.95 | -3.26 | -16.56 | -29.10 | |||
| Statistics | ||||||||
| Gross Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD